Nonprofit · EIN 46-2216869
BBG ADVANCED THERAPIES
Tax-exempt · SAN ANTONIO, TX 78201
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $5,427,037 | $16,040,341 | -$10,613,304 | $23,694,605 | $26,413,626 | -$2,719,021 |
| December 31, 2023 | 990 | $5,040,198 | $15,033,401 | -$9,993,203 | $18,815,048 | $10,920,765 | $7,894,283 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $0
- Program service revenue
- $5,411,797
- Investment income
- $0
- Other revenue
- $15,240
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $314,979
- Other salaries and wages
- $2,933,036
- Salaries, compensation and benefits (total)
- $3,938,486
- Professional fundraising fees
- $0
- Occupancy
- $1,406,336
- Travel
- $45,196
- Depreciation
- $1,674,203
- Program services (functional)
- $11,074,605
- Management and general (functional)
- $4,965,736
Balance sheet and other
- Total assets, start of year
- $18,815,048
- Total assets, end of year
- $23,694,605
- Total liabilities, end of year
- $26,413,626
- Net assets, end of year
- -$2,719,021
- Land, buildings and equipment
- $11,308,310
- Net assets without donor restrictions
- -$2,719,021
- Gross receipts
- $5,427,037
- Employees
- 34
- Volunteers
- 1
- Year formed
- 2013
- State of legal domicile
- TX
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| GEOFFREY KINDT | General Manager, Biomanufacturing (thru 11/02/2024) Key employee | 50 | $260,606 | $28,837 | $84,913 |
| MARI LANE SALMI | SR. DIRECTOR, PROCESS DEV & CELL THERAPIES Highest-paid employee | 50 | $203,361 | $0 | $40,993 |
| ROGELIO ZAMILPA | Executive Director, Biomanufacturing & Collab Highest-paid employee | 50 | $215,099 | $0 | $27,522 |
| MILTON MASAYUKI POLLARD | VP, GENCURE OPERATIONS (thru 07/09/2024) Highest-paid employee | 50 | $196,274 | $0 | $23,473 |
| AMANDA WHITELONIS | Principal Global Market Development (effective 11/03/2024) Highest-paid employee | 50 | $20,119 | $171,875 | $27,276 |
| Miguel Garza | Director, Operations Biomanufacturing Highest-paid employee | 50 | $156,301 | $0 | $19,855 |
| BIOBRIDGE GLOBAL | SOLE MEMBER Institutional trustee | 1 | $0 | $0 | $0 |
990 for the year ended December 31, 2023: 7 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| GEOFFREY KINDT | General Manager, Biomanufacturing (effective 01/29/23) Key employee | 50 | $211,559 | $47,671 | $42,073 |
| MILTON MASAYUKI POLLARD | VP, GENCURE OPERATIONS Highest-paid employee | 50 | $253,559 | $0 | $35,097 |
| CHRISTIE MALONE | SR. DIRECTOR,CUSTOM SOLUTIONS & SALES SUP Highest-paid employee | 25 | $187,962 | $22,575 | $34,058 |
| ROGELIO ZAMILPA | SR. DIRECTOR, MFG SCIENCES & TECHNOLOGY Highest-paid employee | 50 | $209,903 | $0 | $31,260 |
| MARI LANE SALMI | SR. DIRECTOR, PROCESS DEV & CELL THERAPIES Highest-paid employee | 50 | $186,532 | $0 | $36,727 |
| AMANDA WHITELONIS | SR. DIRECTOR, PROGRAM MANAGEMENT (through 11/05/23) Highest-paid employee | 50 | $147,680 | $18,924 | $19,138 |
| BIOBRIDGE GLOBAL | SOLE MEMBER Institutional trustee | 1 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 6211 IH 10 WEST, SAN ANTONIO, TX 78201-2023
- In care of
- % BENJAMIN LOPEZ
- Mailing address (990-N for 2014)
- 6211 I-10 West, San Antonio TX 78201
- Principal officer (990 for 2024)
- MARTIN J LANDON, 6211 IH 10 WEST, SAN ANTONIO, TX 78201
- Principal officer (990-N for 2014)
- Linda Myers, 6211 I-10 West, San Antonio TX 78201
- Signed the 990
- John Youngdahl, SVP, CFO
- Phone
- (210) 757-9505
- Website
- gencure.org
- Return prepared by
- Forvis Mazars LLP
Mission
GENCURE IS ORGANIZED TO FOCUS ON REGENERATIVE MEDICINE AND THE UTILIZATION OF THE POWER OF HUMAN CELLS AND TISSUE TO ENHANCE LIVES AND ENABLE CLINICAL ADVANCEMENTS.
Program accomplishments
- During the reporting year, the organization advanced its enterprise-wide quality and operational infrastructure through several key initiatives. The ISO 9001:2015 certification was successfully renewed and extended to the GenCure site, reinforcing alignment across the Quality Management System and ensuring consistent standards across manufacturing, testing, and clinical operations. A full GMP compliance audit was also completed, verifying adherence to FDA regulations and confirming cGMP readiness across bioproduction and testing facilities. The organization also advanced its quality assurance framework through successful execution of process validation and system qualification activities. These efforts ensured that critical production and testing systems operate consistently within defined parameters, supporting product integrity and regulatory compliance. By validating key processes and qualifying (Continued on Schedule O)Expenses $11,074,605 · revenue $5,427,037
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 46-2216869
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (509(a)(2))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2014
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Health care (E61)
- Assets (IRS master file)
- $23,694,605
- Income (IRS master file)
- $5,427,037
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $5,427,037 | $16,040,341 | $23,694,605 | XML |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $5,040,198 | $15,033,401 | $18,815,048 | XML |
| 990-T | December 2023 | – | – | – | IRS |
| 990 | December 2022 | $5,012,409 | $13,721,023 | $21,827,142 | IRS |
| 990-T | December 2022 | – | – | – | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990-T | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990-T | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
| 990-N for 2014 Officer: Linda Myers | December 31, 2014 | ≤ $50,000 receipts | – | – | e-Postcard |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 46-2216869).
Questions about BBG ADVANCED THERAPIES
- What is the EIN of BBG ADVANCED THERAPIES?
- The employer identification number (EIN) of BBG ADVANCED THERAPIES is 46-2216869.
- Is BBG ADVANCED THERAPIES tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2014.
- Are donations to BBG ADVANCED THERAPIES tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does BBG ADVANCED THERAPIES file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of BBG ADVANCED THERAPIES due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did BBG ADVANCED THERAPIES last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of BBG ADVANCED THERAPIES?
- The 990 for the year ended December 31, 2024 names MARTIN J LANDON.
- Who are the officers and directors of BBG ADVANCED THERAPIES?
- The 990 for the year ended December 31, 2024 lists 7 people; 6 received compensation from the organization, the highest $260,606 (GEOFFREY KINDT, General Manager, Biomanufacturing (thru 11/02/2024)).
- How much revenue does BBG ADVANCED THERAPIES have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $5,427,037, expenses of $16,040,341 and total assets of $23,694,605 at year end.
Other nonprofits in SAN ANTONIO
- CHRISTUS SANTA ROSA HEALTH CARE CORPORATION EIN 74-1109665 · last filed 990 for 2025
- BARRIO COMPREHENSIVE FAMILY HEALTH CARE CENTER INC EIN 74-1724391 · last filed 990 for 2025
- METHODIST HEALTHCARE MINISTRIES OF SOUTH TEXAS INC EIN 74-1287016 · last filed 990 for 2024
- QUALTEX LABORATORIES EIN 20-8429619 · last filed 990 for 2024
- SOUTH TEXAS BLOOD & TISSUE CENTER EIN 23-7379332 · last filed 990 for 2024
- BIO BRIDGE EIN 45-4765222 · last filed 990 for 2024
- SOUTHWEST TEXAS REGIONAL ADVISORY COUNCIL FOR TRAUMA EIN 74-2896432 · last filed 990 for 2025
- CHRISTUS CHILDRENS FOUNDATION EIN 74-1224362 · last filed 990 for 2025